Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19
Articolo
Data di Pubblicazione:
2022
Citazione:
Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19 / A. Galassi, P. Ciceri, V. Bono, L. Magagnoli, M. Sala, L. Artioli, R. Rovito, M. Hadla, V. Yellenki, A. D’Arminio Monforte, C. Tincati, M. Cozzolino, G. Marchetti. - In: BIOMEDICINES. - ISSN 2227-9059. - 10:12(2022 Dec), pp. 3251.1-3251.13. [10.3390/biomedicines10123251]
Abstract:
A cytokine storm drives the pathogenesis of severe COVID-19 infection and several
biomarkers have been linked to mortality. Chronic kidney disease (CKD) emerged as a risk factor
for severe COVID-19. We investigated the association between selected biomarkers and mortality in
77 patients hospitalized for COVID-19, and whether they differ in patients with eGFR higher and
lower than 45 mL/min. The association between patients’ characteristics, plasma biomarkers and
mortality was conducted by univariate logistic regression models and independent predictors of
mortality were then used to create a multivariate prediction model through Cox regression. Patients
with lower eGFR had a significant increase of GDF-15, CD-25 and RAGE, with higher plasma levels
in non-survivors and in patients who needed ventilation. At univariate analysis, low and mid-low
GDF-15 quartiles (<4.45 ng/mL) were associated with lower mortality risk, while mid-high and
high quartiles (>4.45 ng/mL) were associated with higher mortality risk. Independent association
between GDF-15 quartiles and mortality risk was confirmed in the Cox model and adjusted for eGFR,
age, fever and dyspnea (HR 2.28, CI 1.53–3.39, p < 0.0001). The strength of the association between
GDF-15 quartiles and mortality risk increased in patients with lower compared to higher eGFR (HR
2.53, CI 1.34–4.79 versus HR 1.99, CI 1.17–3.39). Our findings may suggest a further investigation of
the effect of GDF-15 signaling pathway inhibition in CKD.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
CKD; COVID-19; GDF-15; mortality
Elenco autori:
A. Galassi, P. Ciceri, V. Bono, L. Magagnoli, M. Sala, L. Artioli, R. Rovito, M. Hadla, V. Yellenki, A. D’Arminio Monforte, C. Tincati, M. Cozzolino, G. Marchetti
Link alla scheda completa:
Link al Full Text: